| Revenue | 7/1/2016 | 7/3/2015 | 6/27/2014 |
| Total Revenue | 12,994,000 | 14,572,000 | 15,130,000 |
| Cost of Revenue | 9,559,000 | 10,351,000 | 10,770,000 |
| Gross Profit | 3,435,000 | 4,221,000 | 4,360,000 |
| Operating Expenses |
| Research Development | 1,627,000 | 1,646,000 | 1,661,000 |
| Selling General and Administrative | 1,342,000 | 964,000 | 908,000 |
| Non Recurring | - | - | - |
| Others | - | - | - |
| Total Operating Expenses | - | - | - |
| Operating Income or Loss | 466,000 | 1,611,000 | 1,791,000 |
| Income from Continuing Operations |
| Total Other Income/Expenses Net | -47,000 | 15,000 | 17,000 |
| Earnings Before Interest and Taxes | 419,000 | 1,626,000 | 1,808,000 |
| Interest Expense | 266,000 | 49,000 | 56,000 |
| Income Before Tax | 153,000 | 1,577,000 | 1,752,000 |
| Income Tax Expense | -89,000 | 112,000 | 135,000 |
| Minority Interest | - | - | - |
| Net Income From Continuing Ops | 242,000 | 1,465,000 | 1,617,000 |
| Non-recurring Events |
| Discontinued Operations | - | - | - |
| Extraordinary Items | - | - | - |
| Effect Of Accounting Changes | - | - | - |
| Other Items | - | - | - |
| Net Income |
| Net Income | 242,000 | 1,465,000 | 1,617,000 |
| Preferred Stock And Other Adjustments | - | - | - |
| Net Income Applicable To Common Shares | 242,000 | 1,465,000 | 1,617,000 |
